NeuroSense reports 65% death risk reduction in ALS trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/27/2026

1. NVDA
2. USO
3. BSP
4. MPLT
5. ITG
6. CAPR
7. SPY
8. XFLT
9. HCA
10. CHTR

Go back to NeuroSense reports 65% death risk reduction in ALS trial
(NASDAQ: NRSN) Delayed: 0.59 -0.01 (1.67%)
Previous Close $0.60    52 Week High $ 
Open $0.62    52 Week Low $ 
Day High $0.63    P/E N/A 
Day Low $0.58    EPS $ 
Volume 86,299       

(NASDAQ: NRSNW) Delayed: 0.06 --0 (-0%)
Previous Close $0.06    52 Week High $ 
Open $0.06    52 Week Low $ 
Day High $0.06    P/E N/A 
Day Low $0.06    EPS $ 
Volume 6